Why the study?
Does exposure to digital cellular telephones cause electromagnetic interference in patients with implantable cardioverter-defibrillators?
Does exposure to digital cellular telephones cause electromagnetic interference in patients with implantable cardioverter-defibrillators?
Digital cellular telephones do not pose a clinically significant risk of electromagnetic interference to patients with the tested implantable cardioverter-defibrillator models.
Answers are grounded in this paper and cite their sources.
Reassures on cellular phone safety near tested ICDs; leaves open effects of newer devices and technologies.
AIMS: To investigate the susceptibility of implantable cardioverter defibrillators to electromagnetic interference generated by digital cellular telephones, functioning in both international transmission technologies: the Global System for Mobile Communication (GSM) and the Digital Cellular System (DCS 1800). METHODS AND RESULTS: In 36 patients with transvenous implantable cardioverter defibrillators from two manufacturers (Medtronic and Guidant/CPI), cellular telephones with different levels of minimal and maximal power output were tested in the transmitting and receiving mode. Evaluation was performed in activated implantable defibrillators during spontaneous cardiac activity and continuous VVI or DDD pacing to assess possible electromagnetic interference. In two patients, appropriateness of ventricular fibrillation detection and therapy was judged during telephone testing. There was no damage, reprogramming, inappropriate shock therapy or pacing inhibition during the tests. In seven pre-pectoral Medtronic implantable defibrillators, transient electromagnetic interference caused 19 erroneous sensing events, when the operating phone was held in close vicinity to the programmer head. These 'pseudo-oversensing' events, which did not result in logging of arrhythmia episodes in the device counter, were interpreted as an adverse interaction between the telephone and the programming device. CONCLUSION: Digital cellular telephones do not represent a risk to Medtronic and Guidant/CPI recipients of the specific implantable defibrillator models herein tested.
No takes yet. Share an insight, caveat, or question.
John Chiladakis (2001) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: